Also, further study of the mechanism of action and appropriate route of administration in a variety of pre‐clinical models of human cancers are critical and important as scFV‐IL‐13Rα2‐CAR‐T cells specifically bind to receptor positive cell and kill them, which may help developing more effective therapeutic strategies in the future. Here, IL13RA2 is linked to cancer.